BriovaRx Infusion Services: Clinical Trials

4 trials sponsored by BriovaRx Infusion Services, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. .

Follow BriovaRx Infusion Services: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
Intravenous Immunoglobulin - Chronic Inflammatory Demyelinating Polyneuropathy
CompletedUniversity of Minnesota302015-03-012020-08-13
Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting
Primary Immunodeficiency Disease (PIDD)
CompletedBriovaRx Infusion Services202014-06-012019-08-07
Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)
Immunoglobulin Therapy - Primary Immune Deficiency Disorder
TerminatedBriovaRx Infusion Services15002013-06-012019-08-07
Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data (GOOD-SHEPARD)
Intravenous Immunoglobulin (IVIg) Therapy in a Home Infusion Setting
TerminatedBriovaRx Infusion Services112012-11-012019-08-07

Conditions studied

Primary Immunodeficiency Diseases (2)  ·  Agammaglobulinemia (1)  ·  Common Variable Immunodeficiency (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)

Interventions

Immunization, Passive (1)  ·  Immunoglobulins, Intravenous (1)

Countries

United States (4)

Top investigators

Jeffrey A Allen, MD (1)  ·  Jeffrey A. Allen, MD (1)

Results publications

PMID 33593867